Clinical Study

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

Table 2

Characteristics of Alzheimer’s disease participants.

Age GenderRaceOD
VA
OS
VA
MMSEFDT
OD
FDT
OS
ReliabilityEye diagnosis

Participants receiving eye screening and anterior segment screening
68FemaleCauFailFail0/fn1None
75MaleCau10/1010/10PassFail0/0Glaucoma
76MaleCau7/80 7/20N/DFail—/fx5Stroke
77Cau7/30 7/10FailFail0/v2none
79Cau7/107/10FailFailfn3/fn2 none
80FemaleCau10/3010/30FailFailfn1/0Cataract
81FemaleCau7/257/25FailFailfp1fn2/fx2fp1fn1None
81FemaleCau7/120 7/120 UnableMacular Degen
81FemaleCau10/1010/10FailFail0/fx1Glaucoma
82Cau10/1010/10PassPass0/0None
83FemaleNatAm7/207/20FailFail0/fx1fp2None
83MaleCau10/2010/20FailFailFn1/fn1Glaucoma
84Cau10/40 10/30FailFail0/fp1 agitatedNone
84MaleCau10/40 10/50 UnableGlaucoma
87FemaleCauFailFailfx2fp1fn2/fp2fn3Cardiac
88FemaleCau10/1010/20FailFail0/0None

Participants receiving comprehensive dilated eye examination and refraction
69FemaleCauPassPass15FailFail3fn/3fnEye exam WNL
70FemaleCauPassPass23FailFail0/0Glaucoma*
72FemaleCauPassPass24FailFail0/0Eye exam WNL*
72MaleCauPassPass26FailPass2fx2fp/5fx5fpEye exam WNL*
85FemaleCauPassPass15FailFail0/0Eye exam WNL
85FemaleCauPassPass17FailFail0/0Eye exam WNL
87FemaleCauPassPass20PassFail0/0Eye exam WNL

Key: Cau: Caucasian, NatAm: Native American, AfrAm: African American, fp: False Positive, fn: false negative, fx: fixation loss, glau: glaucoma, AMD: age-related macular degeneration, CA: cancer, card: cardiac, DM: diabetes, and N/D: not done; *participant had comprehensive eye examination that included optical coherence tomography imaging.